With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

Looking for what to see in theaters? Our feature, updated weekly, highlights our top recommendations for films currently in theaters, from new releases to restorations receiving a proper theatrical ...